In-licensing: Biotechnology & Dermatological & Early Stage

Up-to-date access to technology licensing opportunities worldwide.

In-licensing
Browse

Licensing opportunities

Displaying 1..8 of 8 - per page
Order by

Dermatology: products/technologies for Acne

New Products/Technologies for Acne in early to late phases or already marketed required for acquisition or in-licensing for Mexico More

Seking to purchase or in-license late stage or currently marketed assets.

Seeking late stage or currently marketed assets. More

Products for hospital usage

Pharmaceuticals for pain and wound healing for hospital use More

NCEs, new patented formulations and products

Respiratory; women's care; dermatology; pain relief; GI More

Modified release or Drug delivery/ Cardiovascular/ CNS/ Respiratory/ Dermatology/ GI/ ObGyn/ Oncology/ Biotech

Patent protected/ Innovative/ New products More

Helicon Group has identified the following market segments as high potential for the China market and is seeking innovative technologies to add to its portfolio - Emergency Medicine,ICU, General and Plastic surgery and Oncology.

Helicon has identified Emergency Medicine, General and Cosmetic Surgery and Oncology markets as high potential segments in China and is seeking products with a strategic fit to the existing portfolio. More

Dermatology: Skin Cancer, Anti-fungals, Dermoceuticals & more

New Dermatology products in early to late phases or already marketed required for acquisition or in-licensing for Mexico More

Dermatology: products/Technologies for Atopic Dermatitis

New Products/technologies for Atopic Dermatitis in early to late phases or already marketed required for acquisition or in-licensing for Mexico More

Displaying 1..8 of 8 - per page
Order by

Your selection

Industry sector: Biotechnology del
Therapeutic target: Dermatological del
Development phase: Early Stage del

Browse By

Industry sector: Assay systems; Diagnostic test systems; Gene therapy; Human diagnostics; Human therapeutics; Nanotechnology; Other; Research supplies; Stem cells
Therapeutic target: Acne; Actinic keratosis; Alopecia; Bacterial infection; Burns; Chronic idiopathic urticaria; Cosmetic procedures; Dermal ulcers; Dermatitis, allergic; Dermatitis, atopic; Dermatological (other); Dermatosis; Eczema; Fungal infection; Hirsutism; Human B19 parvovirus; Hyperkeratosis; Ichthyosis; Impetigo; Insect bite; Keloids; Lupus; Male pattern baldness; Paget's disease; Photodamage; Pruritis; Psoriasis; Scleroderma; Shingles; Skin infection (other); Ulcer, diabetic; Urticaria; Wound healing

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us